Recent investigations into retatruptide peptide highlight promising outlook for treating excess body and type 2 diabetes. The peptide, a dual activator of GLP-1 receptor and GIP receptor, seems to provide improved weight loss and glycemic regulation in contrast to existing medications. Ongoing pa